Physician profile
Robert D Plambeck
NPI 1619056256
$194.51
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19.28 · 2020: $31.09 · 2021: $11.48 · 2022: $55.32 · 2023: $48.14 · 2024: $29.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $77.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $77.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $55.10 | 2022-2023 | Injectafer |
| Abbvie INC. | $37.03 | 2019-2020 | |
| Astellas Pharma US INC | $29.20 | 2024 | Veozah |
| Baxter Healthcare | $20.59 | 2023 | Seprafilm |
| Medtronic, INC. | $14.35 | 2022 | |
| Smith+Nephew, INC. | $13.42 | 2023 | Pico, Renasys Go V2 Home |
| Therapeuticsmd, INC. | $13.34 | 2020 | |
| Dysis Medical, INC. | $11.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Plambeck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.